526783 — Dr Agarwals Eye Hospital Balance Sheet
0.000.00%
- IN₹24.53bn
- IN₹26.79bn
- IN₹4.71bn
Annual balance sheet for Dr Agarwals Eye Hospital, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 287 | 280 | 329 | 238 | 997 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 130 | 104 | 134 | 150 | 187 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 500 | 465 | 598 | 559 | 1,365 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,390 | 3,214 | 4,123 | 4,931 | 5,721 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,140 | 3,899 | 4,958 | 6,133 | 7,665 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 534 | 551 | 808 | 870 | 1,114 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,358 | 2,766 | 3,386 | 4,037 | 4,202 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 782 | 1,133 | 1,572 | 2,096 | 3,463 |
| Total Liabilities & Shareholders' Equity | 3,140 | 3,899 | 4,958 | 6,133 | 7,665 |
| Total Common Shares Outstanding |